Product Number : 0186-0776-60
Platelet Aggregation Inhibitors
"BRILINTA is indicated to reduce the rate of cardiovascular death,
myocardial infarction, and stroke in patients with acute coronary
syndrome (ACS) or a history of myocardial infarction (MI).
For at least the first 12 months following ACS, it is superior to clopidogrel.
BRILINTA also reduces the rate of stent thrombosis in patients who have been stented for treatment of ACS.
(reduction of thrombotic events in patients with acute